JW Asset Management, LLC
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 8, 2024), JW Asset Management, LLC reported 13 stock positions worth $242.7 million. Its top holding was Establishment Labs (ESTA) at 59.8% of the portfolio, followed by Nvidia (NVDA, 14.3%) and Abercrombie & Fitch Class A (ANF, 4.8%). Compared with Q1 2024, it opened 2 new positions, sold out of 3, added to 1 and reduced 3. The biggest buy was Nvidia (NVDA, shares +6%) and the biggest sale an exit from Celsius (CELH).
- Most Recent 13F
- Q2 2026
- Location
- MIAMI BEACH, FL
- CIK
- 0001549738
- Portfolio Value
- $242.7M (Q2 2024)
- SEC Filing
- 0001019056-24-000229 ↗ filed Aug 8, 2024
Holdings Value
Holdings 13 stocks · $242.7M
| ESTA Establishment Labs Holdings | 59.77% | 3,192,485 | $145.1M | No change |
| NVDA Nvidia Corp. | 14.32% | 281,250 | $34.7M | Add +6.4% |
| ANF Abercrombie & Fitch Co. Class A | 4.77% | 65,090 | $11.6M | No change |
| NVO Novo-Nordisk A/S-Spons ADR | 4.01% | 68,200 | $9.7M | No change |
| COCO The Vita Coco Co. Inc. | 3.62% | 315,621 | $8.8M | Reduce -8.7% |
| HRTX Heron Therapeutics Inc. | 3.31% | 2,292,418 | $8.0M | No change |
| LLY Eli Lilly & Co. | 3.17% | 8,500 | $7.7M | Reduce -37.0% |
| CPRX Catalyst Pharmaceuticals Inc. | 2.64% | 413,392 | $6.4M | No change |
| MSOS Advisorshares Pure US Cann | 2.51% | 832,283 | $6.1M | Reduce -4.6% |
| IDR Idaho Strategic Resources Inc. | 1.10% | 271,697 | $2.7M | No change |
| HIMS Hims & Hers Health Inc. | 0.54% | 65,000 | $1.3M | New |
| ASPN Aspen Aerogels Inc. | 0.15% | 15,000 | $358K | New |
| HITI High Tide Inc. | 0.09% | 102,144 | $226K | No change |
Portfolio Sells Q1 2024 → Q2 2024
Portfolio Buys Q1 2024 → Q2 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 21 | $319.9M | ESTA, SNDK, COCO, CPRX, MU |
| Q1 2026 | 19 | $243.5M | ESTA, COCO, CPRX, GOOG, IREN |
| Q4 2025 | 18 | $307.2M | ESTA, COCO, HOOD, CPRX, GOOG |
| Q3 2025 | 17 | $208.4M | ESTA, META, HOOD, RBLX, COCO |
| Q2 2025 | 19 | $202.9M | ESTA, META, HOOD, RBLX, CPRX |
| Q1 2025 | 18 | $176.6M | ESTA, CPRX, COCO, META, HRTX |
| Q4 2024 | 17 | $210.4M | ESTA, NVDA, COCO, ANF, CPRX |
| Q3 2024 | 13 | $221.5M | ESTA, NVDA, ANF, COCO, CPRX |
| Q2 2024 | 13 | $242.7M | ESTA, NVDA, ANF, NVO, COCO |
| Q1 2024 | 14 | $273.7M | ESTA, CELH, NVDA, LLY, NVO |